|
Volumn 10, Issue 8, 2002, Pages 358-359
|
Surviving innate immunity [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
CATIONIC ANTIMICROBIAL PEPTIDE;
PEPTIDE DERIVATIVE;
UNCLASSIFIED DRUG;
ABSCESS;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC THERAPY;
BACTERIAL COLONIZATION;
BACTERIAL IMMUNITY;
BACTERIAL INFECTION;
BACTERIAL VIRULENCE;
BACTERIUM MUTANT;
CHEMICAL MODIFICATION;
EPITHELIUM CELL;
GRAM NEGATIVE BACTERIUM;
GRAM POSITIVE BACTERIUM;
HUMAN;
KERATINOCYTE;
LETTER;
MOLECULAR EVOLUTION;
MUCOSA INFLAMMATION;
NONHUMAN;
PATHOGENESIS;
PHAGOCYTOSIS;
PRIORITY JOURNAL;
SALMONELLA;
SPECIES DIFFERENCE;
STAPHYLOCOCCUS AUREUS;
WOUND INFECTION;
ANTI-BACTERIAL AGENTS;
ANTIMICROBIAL CATIONIC PEPTIDES;
BACTERIA;
BACTERIAL INFECTIONS;
CELL WALL;
DRUG RESISTANCE, BACTERIAL;
HUMANS;
IMMUNITY, NATURAL;
BACTERIA (MICROORGANISMS);
NEGIBACTERIA;
POSIBACTERIA;
SALMONELLA;
STAPHYLOCOCCUS;
STAPHYLOCOCCUS AUREUS;
|
EID: 0036684712
PISSN: 0966842X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0966-842X(02)02406-X Document Type: Letter |
Times cited : (4)
|
References (9)
|